https://doi.org/10.1142/S2737416522500016
- There are three Schiff bases synthesized from phenylacetaldehyde (flavanone of tea plants) condense with nucleobases (adenine, and cytosine), and essential amino acid (l-leucine).
- These Schiff bases characterized by UV-visible, FTIR, NMRs (1H, and 13C) spectra.
- Schiff bases structure stability explained by NBO, and ALIE assay; alike, reactivity explained by MESP (both electrical, and nuclear) charges, NLO, and NCI assay; like, biological activity based on QSRA explained by in silico assay.
https://doi.org/10.1142/S2737416522500028
- The binding mode between losartan and GPVI receptor was investigated using molecular simulation method.
- The results show that the phenyltetrazole moiety of losartan binds stably to GPVI, while the imidazole moiety is flexible due to bond rotation.
- Our study may shed light on the mechanism understanding of GPVI receptor, providing insights for future development of novel GPVI inhibitors.
https://doi.org/10.1142/S273741652250003X
- The proposed method explores the shape complementarity of interacting proteins to predict the complex structure.
- An invariant shape descriptor is crucial in shape based docking algorithm.
- Coarse-grained representation of proteins reduces the size of the conformational space.
https://doi.org/10.1142/S2737416522500041
- In this study, two novel molecules were synthesized.
- Theoretical properties such as electronic, spectroscopic, geometric, thermodynamic and non-linear optic (NLO) of molecules were calculated using the DFT(B3LYP, B3PW91, MPW1PW91)/ 6-311++G(d,p) methods and basis set.
- The antioxidant activities of two novel molecules were investigated.
https://doi.org/10.1142/S2737416522500053
- This study performed a full-scale in silico investigations on natural quinazoline alkaloids against the main protease (MPro) of SARS_CoV_2 by examining forty one natural quinazoline alkaloids and identified three alkaloids (CNP0416047, 3-hydroxy anisotine and anisotine) as final lead compounds.
- The screening and structure-based analysis of these ligands were carried out by blending different computational techniques such as rigid docking, pharmacokinetics, flexible docking, E-pharmacophore mapping, DFT studies and MD simulations.
- Mostly, this study added values to quinazoline alkaloids which are fascinating natural pharmacophores and opened the possibilities of in vitro studies of these hit alkaloids in future.
https://doi.org/10.1142/S2737416521410015
- Human African trypanosomiasis (HAT), a fatal infection caused by Trypanosoma brucei, is considered as a neglected disease in the tropical areas, and newer agents with unique mechanism of action are urgently needed.
- In this present work, 65 Imidazopyridine analogues from known literature were selected for building statistically robust genetic algorithm (GA) based QSAR models. Furthermore, values for the various cross-validation properties supported its statistical robustness.
- Our in-silico ADMET analysis revealed that a designed molecule, S10 may act as potent lead (T. brucei, pEC 50 (μM), predicted = 8.200) with better pharmacokinetics, no carcinogenicity, class III acute oral toxicity, minimal OCT1 and OCT2 inhibitions, and no eye corrosion profiles.
https://doi.org/10.1142/S2737416521410027
- This is the first report showing virtual screening and molecular docking studies of sulfacetamide derivatives as new antimicrobial drugs.
- Belonging to pharmacological class of sulfonamides to identify novel candidate drugs against new dihydropteroate synthase inhibitors (DHPS).
- The new derivatives can be used in drug improvement processes for the treatment of antibacterial infections after performing further studies.
https://doi.org/10.1142/S2737416521410039
- The emerging coronavirus disease (COVID-19) distributes promptly in the world wide.
- Virtual screening, molecular docking base on quinoline scaffold are able to be used to identify novel drugs candidate against COVID-19.
- Some new quinolone -based compounds with low energy binding were selected as the inhibitors of SARS-CoV-2 main protease site, spike protein, and RBD/ACE2.